MoonLake Immunotherapeutics MLTX Switzerland — Long-Lived Assets

Other geography segments

Similar metrics at other companies

PMSwitzerland: — Long-Lived Assets

$1.7B+21.4%

FMCSwitzerland — Long-Lived Assets

$1.41B-31.4%

CMPRSWITZERLAND — Long-Lived Assets

$76.15M+4.4%

AVYChina Including Hong Kong — Long-Lived Assets

$273M-5.2%

PANWIsrael — Long-Lived Assets

$162.1M+14.9%

FNOthers — Long-Lived Assets

$590K+38.8%

FAQ

What is MoonLake Immunotherapeutics's switzerland — long-lived assets?

MoonLake Immunotherapeutics (MLTX) reported switzerland — long-lived assets of $888K in Q1 2026.

How has MoonLake Immunotherapeutics's switzerland — long-lived assets changed year-over-year?

MoonLake Immunotherapeutics's switzerland — long-lived assets increased by 64.7% year-over-year, from $539K to $888K.

What does switzerland — long-lived assets mean?

This metric quantifies the total book value of non-current, tangible, and intangible assets held by the company within the specified geographic segment. These assets typically include property, plant, equipment, and other long-term investments essential for regional operations. It serves as a key indicator of the capital intensity and physical presence maintained by the company in that specific market.